Evaluating the Impact of Administration of Ocrelizumab via Home Infusion on Safety and Patient Reported Outcomes

被引：0
|
作者：
Barrera, Britney [1 ]
Simpson, Haley [1 ]
Engebretson, Eric [1 ]
Sillau, Stefan [1 ]
Valdez, Brooke [1 ]
Gonzalez, Jose Parra [1 ]
Winger, Ryan [2 ]
Alvarez, Enrique [1 ]
Gross, Robert [1 ]
Piquet, Amanda [1 ]
Schreiner, Teri [1 ]
Corboy, John [1 ]
Pei, Jinglan [2 ]
Vollmer, Timothy [1 ]
Nair, Kavita [1 ]
机构：
[1] Univ Colorado, Neurol, Boulder, CO USA
[2] Genentech Inc, San Francisco, CA USA
来源：
NEUROLOGY | 2022年 / 98卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P16-4.005
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Evaluating the Impact of Administration of Ocrelizumab via Home Infusion on Safety and Patient Reported Outcomes
    Barrera, B.
    Simpson, H.
    Engebretson, E.
    Sillau, S.
    Valdez, B.
    Gonzalez, J. Parra
    Winger, R.
    Alvarez, E.
    Gross, R.
    Piquet, A.
    Schreiner, T.
    Corboy, J. R.
    Pei, J.
    Vollmer, T.
    Nair, K.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (1_SUPPL) : 199 - 200
  • [2] Safety and patient experience with at-home infusion of ocrelizumab for multiple sclerosis
    Barrera, Britney
    Simpson, Haley
    Engebretson, Eric
    Sillau, Stefan
    Valdez, Brooke
    Parra-Gonzalez, Jose
    Winger, Ryan C.
    Epperson, Lou Anne
    Banks, Ashley
    Pierce, Kathryn
    Spotts, Melanie
    O'Gean, Katie
    Alvarez, Enrique
    Gross, Robert
    Piquet, Amanda L.
    Schreiner, Teri
    Corboy, John R.
    Pei, Jinglan
    Vollmer, Timothy L.
    Nair, Kavita V.
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2023, 10 (04): : 579 - 588
  • [3] VALIDATION OF PATIENT REPORTED OUTCOMES MEASURES (PROMS) IN A HOME INFUSION MODEL
    Ayer, G.
    Christopher-Stine, L.
    Ladha, S.
    Mozaffar, T.
    So, Y. T.
    Silvestri, N.
    MUSCLE & NERVE, 2014, 50 : S5 - S5
  • [4] EVALUATING THE IMPACT OF PATIENT REPORTED OUTCOMES DATA ON HTA REIMBURSEMENT DECISIONS
    Sharma, G.
    Naujoks, C.
    Booneti, S.
    Lokho, J.
    Kommineni, J.
    VALUE IN HEALTH, 2022, 25 (01) : S184 - S185
  • [5] Impact of Subcutaneous Levodopa Infusion with ND0612 on Patient Reported Outcomes
    Ellenbogen, Aaron
    Stocchi, Fabrizio
    Espay, Alberto
    Poewe, Werner
    Oren, Sheila
    Case, Ryan
    Olanow, C. Warren
    NEUROLOGY, 2020, 94 (15)
  • [6] VALIDATION OF PATIENT REPORTED OUTCOMES IN OBTAINED IN THE HOME INFUSION SETTING IN THE MANAGEMENT OF PATIENTS WITH NEUROMUSCULAR DISEASE
    Ayer, Gretchen
    Christopher-Stine, Lisa
    Ladha, Shafeeq
    Mozaffar, Tahseen
    So, Yuen
    Silvestri, Nicholas
    MUSCLE & NERVE, 2014, 50 (04) : 674 - 674
  • [7] Real World Patient Reported Outcomes Evaluating the Impact of Hematologic Malignancies on Patient Quality of Life
    Hoff, Fieke W.
    Madanat, Yazan F.
    Glassner, Heather Lapidus
    Schneider, Beth
    BLOOD, 2022, 140 : 8070 - 8071
  • [8] Patient-reported outcomes Recording and evaluating patient-reported endpoints
    Hilser, Thomas
    Darr, Christopher
    Gruenwald, Viktor
    ONKOLOGIE, 2022, 28 (10): : 940 - 946
  • [9] Tolerability and Safety of Switching from Rituximab to Ocrelizumab: Evaluating Factors Associated with Infusion Related Reactions
    Alvarez, Enrique
    Nair, Kavita, V
    Sillau, Stefan
    Shelton, Ian
    Seale, Rebecca
    Selva, Sean
    Corboy, John
    Vollmer, Timothy L.
    MULTIPLE SCLEROSIS JOURNAL-EXPERIMENTAL TRANSLATIONAL AND CLINICAL, 2022, 8 (01)
  • [10] Tolerability and safety of switching from rituximab to ocrelizumab: evaluating factors associated with infusion related reactions
    Alvarez, E.
    Nair, K.
    Shelton, I.
    Sillau, S.
    Vollmer, T.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 775 - 775
12345